An EHR-integrated Texting Platform to Promote Self-management in Women With Recurrent Urinary Tract Infections
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Recurrent Urinary Tract Infection
- Sponsor
- University of Pennsylvania
- Enrollment
- 104
- Locations
- 1
- Primary Endpoint
- Rate of unnecessary antibiotics
- Status
- Completed
- Last Updated
- 8 months ago
Overview
Brief Summary
The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI).
The main question it aims to answer is:
• can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care?
Participants enrolled onto the texting platform will:
• receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.
Investigators
Lily Arya
Professor of OBGYN
University of Pennsylvania
Eligibility Criteria
Inclusion Criteria
- •Provision of signed and dated informed consent form
- •Stated willingness to comply with all study procedures and availability for the duration of the study
- •Females who currently meet the criteria for recurrent UTIs
- •Age 18 years or older
- •Owns a mobile device with text messaging capability
- •Ability to read and write English
- •Currently receiving care from a provider in Penn Urogynecology or Penn Urology
- •Exclusion criteria:
- •History of known multidrug resistant UTIs
- •History of interstitial cystitis/bladder pain syndrome or current diagnosis of chronic pelvic pain
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Rate of unnecessary antibiotics
Time Frame: 3 months
Antibiotics prescribed for patients when 1) urine culture is negative and/or urine microscopy has pyuria \< 10 WBC/HPF, 2) asymptomatic bacteriuria is present, or 3) there is no urine testing and no urinary symptoms.
Secondary Outcomes
- Healthcare-related quality of life: Recurrent UTI Impact Questionnaire score(3 months)
- Antibiotic prescriptions(3 months)
- Patient self-efficacy(3 months)
- Healthcare utilization(3 months)
- Patient medication compliance(3 months)
- Patient satisfaction: Patient Global Impression of Improvement score(3 months)
- Healthcare-related quality of life: EQ-5D-5L score(3 months)